Clinical trial
IMplementation of a Randomized Controlled Trial (RCT) to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation
NCT03259373 is registered in ClinicalTrials.gov with Harvard Pilgrim Health Care as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- IMplementation of a Randomized Controlled Trial (RCT) to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation
- Lead sponsor
- Harvard Pilgrim Health Care
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 25, 2017
- Completion date
- December 31, 2021
- Enrollment
- 64,666 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.